The Emcure Pharma IPO subscription status started on July 03, 2024, and QIB, NII, and RII are also subscribing to it. The Emcure Pharma IPO opens on July 03, 2024, and closes on July 05, 2024. Emcure Pharma IPO is preparing to raise ₹1952.03 crores through its fresh issue and offer for sale, in which the fresh issue is ₹800.00 crores and the offer for sale is ₹1152.03 crores, and the Emcure Pharma IPO price band is fixed ₹960 to ₹1008 per share. You Can check Emcure Pharma IPO GMP here.
Emcure Pharmaceuticals is a leading Indian pharmaceutical company engaged in developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company is a research and development (“R&D”) driven company with a differentiated product portfolio that includes orals, injectables, and biotherapeutics, which has enabled us to reach a range of target markets across over 70 countries, with a strong presence in India, Europe, and Canada.
Emcure Pharma IPO reserved shares in this IPO, 50% for QIB 15% for NII, and 35% for the retail category have been reserved. To know the Emcure Pharma IPO Subscription Status, you can see the below-day Subscription. You can check Emcure Pharma’s IPO Allotment status here.
Emcure Pharma IPO Review :
Show Review…….
- ■ Emcure Pharmaceuticals Ltd is an Indian leading R & D driven pharmaceutical company.
- ■ The company top line strong & bottom line posted declining trends with higher provisions for interest and depreciations.
- ■ The Company PE ratio of the company is slightly high.
- ■ The company Issue price is slightly aggressive based on the PE Ratio but the company growth line is clear.
- ■ Based on FY24 the issue appears fully priced, Investors can bid the long-term investing.
Emcure Pharma IPO Subscription Status {Live Update} :
The total Emcure Pharma IPO Subscription Status subscribed 67.87x times so far, with QIB subscribed 195.83x NII subscribed 48.32x times & RII 7.21x times, and EMP 8.81x times on Day 3. (Closed)
| Category | Day 1 | Day 2 | Day 3 |
| QIB : | 0.07x | 1.00x | 195.83x |
| NII : _________ bNII (above ₹10L): sNII (below ₹10L): | 2.78x ______ 2.00x 2.18x | 13.67x ______ 14.15x 12.70x | 48.32x ______ 53.79x 37.39x |
| RII : | 1.46x | 3.43x | 7.21x |
| EMP : | 2.34x | 4.83x | 8.81x |
| Total : | 1.34x | 4.98x | 67.87x |
Emcure Pharma IPO Net Shares Offered:
Emcure Pharma IPO is a public issue of 19,483,388 equity shares. The issue offers 3,853,234 shares to qualified institutional buyers, 2,889,926 shares to non-institutional investors, and 6,743,160 shares to retail investors.
| Category | Net EQ Offer | Amount(in Cr) |
| Anchor : | 5,779,850 | 582.61 |
| QIB : | 3,853,234 | 388.41 |
| NII : ________________________ bNII (bids above ₹10L) : sNII (bids below ₹10L) : | 2,889,926 ______________ 1,926,618 963,309 | 291.30 _______ 194.20 97.10 |
| RII : | 6,743,160 | 679.71 |
| EMP : | 108,900 | 10.98 |
| Total : | 19,483,388 | 1963.93 |
Investor Categories Define :
■ Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, Mutual Funds, insurance companies, and pension schemes.
■ Non-Institutional Investors(NII): Retail Individual Investors, NRIs, Companies, Trusts, etc
● sNII (bids below Rs 10L): The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category.
● bNII (bids above Rs 10L): The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory.
■ Retail Individual Investors (RII): Retail Individual Investors or NRIs
■ Employee (EMP): Eligible Employees
■ Others: Eligible Shareholders
Emcure Pharma IPO Subscription Status FAQs :
How much is the total Emcure Pharma IPO Subscription Status?
The total Emcure Pharma IPO Subscription Status is 67.87x times Day 3.
What is the Emcure Pharma IPO retail subscription Status?
Emcure Pharma IPO Retail Subscription 7.21x times Day 3.
What is the Emcure Pharma IPO QIB subscription Status?
The Emcure Pharma IPO QIB subscription is 48.32x times Day 3.
What is the Emcure Pharma IPO NII subscription status?
Emcure Pharma IPO NII Subscription 195.83x times Day 3.
When is the Emcure Pharma IPO Allotment Date?
Emcure Pharma’s IPO allotment date is July 08, 2024.
When is the Emcure Pharma IPO Listing Date?
Emcure Pharma’s IPO listing date is July 10, 2024. The IPO is to be listed on BSE and NSE.
How to Apply the Emcure Pharma IPO through Zerodha?
Log in to the Console on the Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Emcure Pharma IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Emcure Pharma IPO through Upstox?
Log in to the Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Emcure Pharma IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Emcure Pharma IPO through Groww?
Log in to the Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Emcure Pharma IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
How to Apply the Emcure Pharma IPO through Paytm Money?
Log in to the Paytm Money Website or app. Now you can see Invest in IPOs Section and Click on IPO. You will see the IPO Name “Emcure Pharma IPO”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
| Emcure Pharma IPO GMP: Click Here Emcure Pharma IPO Details: Click Here Emcure Pharma IPO Allotment: Click Here Emcure Pharma IPO Listing: Click Here |
All Emcure Pharma IPO-related links are available here. If you want to know the details then click on the Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME-RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.